{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q98234",
      "entity_text" : "GSH-Px",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10116" ],
      "TissueType" : [ "tissuelist:TS-0110" ],
      "Organ" : [ "uberon:UBERON:0002484" ],
      "CellType" : [ "cl:CL:0000136" ]
    }
  },
  "verbose_text" : "Compared with model group, the level of MDA in the APS groups (200mg/kg, 400mg/kg, 800mg/kg dose) after administration were significantly decreased (p < 0.01), and the levels of GSH-Px and SOD in the APS high-dose group (800mg/kg dose) were significantly increased (p < 0.05, XREF_FIG).",
  "reading_complete" : "2020-08-05T19:22:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T19:21:59Z",
  "trigger" : "levels",
  "evidence" : [ "levels of GSH-Px" ],
  "pmc_id" : "6583917",
  "score" : 0
}